154 related articles for article (PubMed ID: 36109473)
21. Formulation and Evaluation of Supramolecular Food-Grade Piperine HP β CD and TPGS Complex: Dissolution, Physicochemical Characterization, Molecular Docking, In Vitro Antioxidant Activity, and Antimicrobial Assessment.
Imam SS; Alshehri S; Alzahrani TA; Hussain A; Altamimi MA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066657
[TBL] [Abstract][Full Text] [Related]
22. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-beta-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component.
Basavaraj S; Sihorkar V; Shantha Kumar TR; Sundaramurthi P; Srinivas NR; Venkatesh P; Ramesh M; Kumar Singh S
Pharm Dev Technol; 2006; 11(4):443-51. PubMed ID: 17101515
[TBL] [Abstract][Full Text] [Related]
23. Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes.
Elbary AA; Kassem MA; Abou Samra MM; Khalil RM
Drug Discov Ther; 2008 Apr; 2(2):94-107. PubMed ID: 22504505
[TBL] [Abstract][Full Text] [Related]
24. Stimulatory Effects of Soluplus® on Flufenamic Acid β-Cyclodextrin Supramolecular Complex: Physicochemical Characterization and Pre-clinical Anti-inflammatory Assessment.
Alshehri S; Imam SS; Altamimi MA; Hussain A; Shakeel F; Alshehri A
AAPS PharmSciTech; 2020 May; 21(5):145. PubMed ID: 32430787
[TBL] [Abstract][Full Text] [Related]
25. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
Rao MRP; Chaudhari J; Trotta F; Caldera F
AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
[TBL] [Abstract][Full Text] [Related]
26. Binary and ternary complex formation and characterization of artemisinin with sulfobutyl ether β-cyclodextrin and oleic acid.
Yousaf Shahzad M; Abbas M; Ansari MT; Abbas M
Pak J Pharm Sci; 2024 Jan; 37(1):43-52. PubMed ID: 38741399
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
28. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
Mummidi V; Jayanthi V
Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
[TBL] [Abstract][Full Text] [Related]
29. Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin.
Medarević D; Kachrimanis K; Djurić Z; Ibrić S
Eur J Pharm Sci; 2015 Oct; 78():273-85. PubMed ID: 26255049
[TBL] [Abstract][Full Text] [Related]
30. Cyclodextrin-Based Supramolecular Ternary Complexes: Emerging Role of Ternary Agents on Drug Solubility, Stability, and Bioavailability.
Suvarna P; Chaudhari P; Lewis SA
Crit Rev Ther Drug Carrier Syst; 2022; 39(5):1-50. PubMed ID: 35993995
[TBL] [Abstract][Full Text] [Related]
31. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
32. Physicochemical and molecular modeling studies of cefixime-L-arginine-cyclodextrin ternary inclusion compounds.
Jadhav P; Petkar B; Pore Y; Kulkarni A; Burade K
Carbohydr Polym; 2013 Nov; 98(2):1317-25. PubMed ID: 24053809
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
[TBL] [Abstract][Full Text] [Related]
34. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
[TBL] [Abstract][Full Text] [Related]
35. Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies.
Manca ML; Zaru M; Ennas G; Valenti D; Sinico C; Loy G; Fadda AM
AAPS PharmSciTech; 2005 Oct; 6(3):E464-72. PubMed ID: 16354006
[TBL] [Abstract][Full Text] [Related]
36. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
[TBL] [Abstract][Full Text] [Related]
37. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
Guo B; Zhong S; Li N; Li X; Yi J; Jin M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
[TBL] [Abstract][Full Text] [Related]
38. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin.
Shanmuga Priya A; Sivakamavalli J; Vaseeharan B; Stalin T
Int J Biol Macromol; 2013 Nov; 62():472-80. PubMed ID: 24076034
[TBL] [Abstract][Full Text] [Related]
39. Formulation of Silymarin-β Cyclodextrin-TPGS Inclusion Complex: Physicochemical Characterization, Molecular Docking, and Cell Viability Assessment against Breast Cancer Cell Lines.
Imam SS; Alshehri S; Altamimi MA; Mahdi WA; Qamar W
ACS Omega; 2023 Sep; 8(38):34898-34907. PubMed ID: 37779986
[TBL] [Abstract][Full Text] [Related]
40. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
